Thermo Fisher Scientific | TMO - Stammkapital

Aktienkurs
468.84
Täglich Wechseln
-0.87 -0.19%
Monatlich
-4.47%
Jährlich
10.51%
Q2 Prognose
459.66




Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Agilent USD 282.7M 358K 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio Techne USD 155.75M 154.18M 2025-09
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Boston Scientific USD 1.48B 2.66M 2025-12
Bruker USD 151.94M 225K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 199.5M 196.5M 2025-09
Edwards Lifesciences USD 580.7M 0 2025-12
General Electric Aerospace USD 1.04B 5.43M 2026-03
Henry Schein USD 115.77M 2.8M 2025-12
Illumina USD 152.8M 900K 2025-12
Intuitive Surgical USD 355.17M 674K 2026-03
IQVIA Holdings USD 169.6M 700K 2025-12
Laboratory Of America USD 82.2M 700K 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Mettler Toledo International USD 20.43M 170.6K 2025-12
Myriad Genetics USD 93.5M 400K 2025-12
Olympus JPY 1.1B 6.86M 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Quest Diagnostics USD 111M 1000K 2026-03
Repligen USD 56.32M 42K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Stryker USD 382.4M 93K 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Veracyte USD 79.05M 377K 2025-12
Waters USD 98.08M 38.55M 2025-12
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12